21Feb 2025
CKD Exacerbates PAD Pathology through Metabolic and Muscle Dysfunction

CKD Exacerbates PAD Pathology through Metabolic and Muscle Dysfunction

Uremic toxins may offer therapeutic targets to improve muscle health in PAD patients with CKD. The study of 123 participants (28 controls, 46 PAD-only, 31 CKD-only, 18 PAD + CKD) shows how CKD exacerbates PAD, reducing muscle strength by 40%, impairing mitochondrial function, and altering gene expression. Using multiomics, significant correlations between uremic toxins and muscle dysfunction were found. Targeting these changes could improve patient outcomes.

  • #cardiology

Like

Save

Share